Schott Kaisha has announced an immediate investment of Rs 105 crore ( approximately EUR 12 million) into its existing facilities to increase its vial production by 300 million pieces. The decision comes at a time when drug manufacturers around the world are undergoing Covid-19 vaccine trials. Such complex medications are…
Choose your subscription to read more
Trial
₹ 0 /mo
Not sure which package to choose?
Try full access
- ₹ 0 for 4 weeks*
PSA Plan 1
₹ 1000 /year
Access to the website, weekly eMail newsletter
- ₹1,000.00 for 1 year*
PSA Plan 2
₹ 1500 /Year
Access to the website, weekly eMail newsletter and monthly eMag
- ₹1500 for Year*
PSA Plan 3
₹ 2000 /Year
Print Copy, access to the website, weekly eMail newsletter and monthly eMag
- ₹2,000.00 for 1 year*
